Roger H. Brookes

Product R&D
Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Formulation development of a stable influenza recombinant neuraminidase vaccine candidate.

Formulation development of a stable influenza recombinant neuraminidase vaccine candidate.

Journal: Human vaccines & immunotherapeutics

Published: March 18, 2024

Aluminum hydroxide adjuvant diverts the uptake and trafficking of genetically detoxified pertussis toxin to lysosomes in macrophages.

Aluminum hydroxide adjuvant diverts the uptake and trafficking of genetically detoxified pertussis toxin to lysosomes in macrophages.

Journal: Molecular microbiology

Published: January 21, 2022

Immunocartography: Charting vaccine-driven immunity by applying single cell proteomics to an in vitro human model.

Immunocartography: Charting vaccine-driven immunity by applying single cell proteomics to an in vitro human model.

Journal: Journal of immunological methods

Published: December 18, 2020

Genetically detoxified pertussis toxin displays near identical structure to its wild-type and exhibits robust immunogenicity.

Genetically detoxified pertussis toxin displays near identical structure to its wild-type and exhibits robust immunogenicity.

Journal: Communications biology

Published: March 02, 2020

Mycobacterium tuberculosis Infection in Close Childhood Contacts of Adults with Pulmonary Tuberculosis is Increased by Secondhand Exposure to Tobacco.

Mycobacterium tuberculosis Infection in Close Childhood Contacts of Adults with Pulmonary Tuberculosis is Increased by Secondhand Exposure to Tobacco.

Journal: The American journal of tropical medicine and hygiene

Published: July 20, 2017

An adjuvant-modulated vaccine response in human whole blood.

An adjuvant-modulated vaccine response in human whole blood.

Journal: Human vaccines & immunotherapeutics

Published: June 13, 2017

Screening Vaccine Formulations in Fresh Human Whole Blood.

Screening Vaccine Formulations in Fresh Human Whole Blood.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: October 09, 2016

A bivalent pneumococcal histidine triad protein D-choline-binding protein A vaccine elicits functional antibodies that passively protect mice from Streptococcus pneumoniae challenge.

A bivalent pneumococcal histidine triad protein D-choline-binding protein A vaccine elicits functional antibodies that passively protect mice from Streptococcus pneumoniae challenge.

Journal: Human vaccines & immunotherapeutics

Published: July 09, 2016

A high ratio of IC31(®) adjuvant to antigen is necessary for H4 TB vaccine immunomodulation.

A high ratio of IC31(®) adjuvant to antigen is necessary for H4 TB vaccine immunomodulation.

Journal: Human vaccines & immunotherapeutics

Published: May 22, 2015

Passive protection of mice against Streptococcus pneumoniae challenge by naturally occurring and vaccine-induced human anti-PhtD antibodies.

Passive protection of mice against Streptococcus pneumoniae challenge by naturally occurring and vaccine-induced human anti-PhtD antibodies.

Journal: Human vaccines & immunotherapeutics

Published: April 28, 2015

Screening vaccine formulations for biological activity using fresh human whole blood.

Screening vaccine formulations for biological activity using fresh human whole blood.

Journal: Human vaccines & immunotherapeutics

Published: January 10, 2014

Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in children.

Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in children.

Journal: The Pediatric infectious disease journal

Published: May 23, 2013

Showing 1-12 of 15

Last Updated: 09/26/2026